Lenalidomide and Risk of Acute Myeloid Leukemia (AML) Transformation Among Myelodysplastic Syndrome (MDS) Patients

被引：0

作者：

Rollison, Dana E. ^{[1
]}

Shain, Kenneth H. ^{[1
]}

Lee, Ji-Hyun ^{[2
]}

Hampras, Shalaka S. ^{[1
]}

Fulp, William ^{[1
]}

Fisher, Kate ^{[1
]}

Al Ali, Najla H. ^{[1
]}

Padron, Eric ^{[3
]}

Lancet, Jeffrey ^{[1
]}

Xu, Qiang ^{[4
]}

Knight, Robert D. ^{[4
]}

List, Alan F. ^{[1
]}

Dalton, William ^{[1
]}

Komrokji, Rami ^{[1
]}

机构：

[1] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA

[2] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA

[3] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA

[4] Celgene Corp, Summit, NJ USA

来源：

BLOOD | 2014年 / 124卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[1] Erythropoietin (EPO)-dependent transformation of myelodysplastic syndrome (MDS) to acute myeloid leukemia (AML).
Bunworasate, U
Arnouk, H
Minderman, H
O'Loughlin, KL
Sait, SNJ
Barcos, M
Baer, MR
[J]. BLOOD, 2000, 96 (11) : 259B - 259B
[2] Symptom Burden In Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Williams, Loretta A.
Ault, Patricia S.
Kantarjian, Hagop M.
Garcia-Manero, Guillermo
Quintas-Cardama, Alfonso
Borthakur, Gautam
Faderl, Stefan H.
Jabbour, Elias J.
Cleeland, Charles S.
Cortes, Jorge E.
[J]. BLOOD, 2013, 122 (21)
[3] Transformation of myelodysplastic syndrome (MDS) to hypocellular Acute Myeloid Leukemia (AML) post renal transplant.
Hasni, K
Gunnala, V
Shah, M
Hoang, T
Kung, SC
Brodsky, I
Kumar, MA
Heifets, M
[J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 923A - 923A
[4] Myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in Down syndrome: Pathologic aspects
Mast, K.
Taub, J. W.
Alonzo, T.
Mosse, C.
Gamis, A. S.
Mathew, P.
Jones, H.
Hitzler, J.
Head, D. R.
[J]. LEUKEMIA RESEARCH, 2013, 37 : S89 - S90
[5] Comparison of Symptom Burden in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Williams, Loretta A.
Ahaneku, Hycienth
Cortes, Jorge E.
Manero, Guillermo Garcia
Kantarjian, Hagop M.
Shi, Qiuling
Lin, Huei-Kai
Limaye, Achala R.
Cleeland, Charles S.
[J]. BLOOD, 2014, 124 (21)
[6] A Final Report: Phase I/II Study of Sequential Azacitidine and Lenalidomide in Patients with Higher-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
DiNardo, Courtney D.
Daver, Naval
Jabbour, Elias
Kadia, Tapan
Borthakur, Gautam
Konopleva, Marina
Pemmaraju, Naveen
Yang, Hui
Wei, Yue
Wierda, William G.
Bueso-Ramos, Carlos E.
Patel, Keyur P.
Cortes, Jorge E.
Ravandi, Farhad
Kantarjian, Hagop
Garcia-Manero, Guillermo
[J]. BLOOD, 2014, 124 (21)
[7] Diagnostic of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
Germing, Ulrich
Haferlach, Torsten
[J]. LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2015, 39 (05): : 291 - 299
[8] Homoharringtonine in patients with myelodysplastic syndrome (MDS) and MDS evolving to acute myeloid leukemia
Feldman, EJ
Seiter, KP
Ahmed, T
Baskind, P
Arlin, ZA
[J]. LEUKEMIA, 1996, 10 (01) : 40 - 42
[9] Efficacy of Lenalidomide and Bortezomib for Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapsing after Allogeneic Stem Cell Transplantation
Brunner, Andrew M.
Blonquist, Traci M.
McMasters, Malgorzata
Hobbs, Gabriela S.
McAfee, Steven L.
Rosenblatt, Jacalyn
Amrein, Philip C.
Connolly, Christine
Ramos, Aura Y.
Mikami, Kaleb
Logan, Emma
Dey, Bimalangshu R.
Spitzer, Thomas
Avigan, David E.
Chen, Yi-Bin
Ballen, Karen K.
El-Jawahri, Areej
Fathi, Amir T.
[J]. BLOOD, 2018, 132
[10] The development of pevonedistat in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML): hope or hype?
Snow, Anson
Zeidner, Joshua F.
[J]. THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13

← 1 2 3 4 5 →